See Our Latest Insights
on the impacts of COVID-19.

COVID-19: Update on the Federal Government’s Healthcare Response

Mar 18 2020

Rick Weissenstein, Cowen Washington Research Group’s Health Care Services & Pharmaceutical Policy analyst and Eric Assaraf, Cowen Washington Research Group’s Health Care & Medical Devices analysts speak with Michael McCaughan, Founding Member, Prevision Policy, Adriel Bettelheim, Health Care Editor, POLITICO and David Lim, Health Care Reporter, POLITICO.

They speak about the latest on the federal government’s healthcare response to COVID-19, recent administrative and legislative actions along with agency initiatives at HHS, CDC, and CMS and the potential impact of COVID-19 on FDA drug reviews and the elections.

Press play below to hear the full discussion.

Get in touch

Reach out to us directly for more information.

More Like This

Lyrically Speaking

May 18, 2020

Lyrically Speaking: Hold Your Head Up!

Read More

May 11, 2020

The Disconnect Between the Stock Market and the Economy

Read More

May 1, 2020

Economic Uncertainty Continues to Impact Aerospace & Defense

Read More